Valeant in Europe

Office in Warsaw

In result of purchasing Czech, Hungarian and Slovakian Companies, ICN Polfa Rzeszów S.A. became a sole owner and representative of Valeant Pharmaceuticals in Europe. It caused a change of hitherto name of the region from „Central Europe” to „Europe” and establishing a position of President Europe, whom the current President of the Management Board – Mariusz Gajowniczek has been appointed.

The office, which is located at 15 Marynarska St. in Warsaw, is the centre of management for Europe.
The Company Management Board, First Management Line including the HR and Administration Director, Regulatory Affairs Director, Business Development Director and Business Units Managers work there.
The office comprises also marketing department, which provides information on needs and expectations of the market and sales department, which plans and supports current production and auxiliary departments.